Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

  • There is currently no data for DEMG

Director/PDMR Shareholding

25 May 2006 16:00

Deltex Medical Group PLC25 May 2006 25 May 2006 Deltex Medical Group plc Directors' Shareholdings Deltex Medical Group plc (the "Company"), the AIM quoted haemodynamic monitoringcompany, announces that it has today issued a total of 149,347 new ordinaryshares in the Company to certain non-executive directors and certain advisors tothe Company at a price of 20.00 pence per share. The five non-executive directors named below have elected to take shares in lieuof a cash payment as remuneration for their services to the Company. Inaddition certain of the Company's advisors have elected to take shares in lieuof cash payment for their services to the Company. Accordingly, application has been made for these shares to be admitted totrading on AIM. The shares rank pari passu with the existing issued shares ofthe Company and dealings are expected to commence on 01 June 2006. Followingthe issue of these new shares the Company has a total of 76,698,563 ordinaryshares in issue. Following this issue, the directors' beneficial interests are as follows: Name of Director Number of new Holding of shares following % of enlarged issued ordinary shares issue of new ordinary shares share capital issued in lieu of fees Nigel Keen (1) 31,250 4,187,546 5.46%Dr Edwin Snape (2) 22,500 3,207,750 4.18%Peter Smedvig (3) 22,500 1,142,115 1.49%Andy Hill - 172,486 0.22%Ewan Phillips - 767,156 1.00%George Flouty 26,257 295,335 0.39%Sir Duncan Nichol 17,550 71,015 0.09% Total 120,057 9,843,403 12.83% (1) Includes 589,700 shares held as trustee and executor of Pauline ThomasCharity Will Trust. (2) Includes shares held as a director of New England Partners andassociated companies. (3) Includes shares held as director of Peder Smedvig Capital AS. For further information, please contact:- Deltex Medical Group plc 01243 774 837Nigel Keen, Chairman nigel.keen@deltexmedical.comAndy Hill, Chief Executive andy.hill@deltexmedical.comEwan Phillips, Finance Director ewan.phillips@deltexmedical.com Charles Stanley 0207 953 2000Philip Davies Financial DynamicsDavid Yates/John Gilbert 0207 831 3113 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Feb 20237:00 amRNSConvertible loan notes repayment date extension
24th Jan 20237:00 amRNSYear end trading update
22nd Dec 20227:00 amRNSYear end update
20th Sep 20227:00 amRNSInterim Results
14th Jul 20227:00 amRNSCompletion of Nominated Adviser due diligence
7th Jul 20227:00 amRNSHalf year trading update
18th May 20223:41 pmRNSResult of AGM
18th May 20227:00 amRNSChairman's Statement to Annual General Meeting
28th Apr 20227:00 amRNSChange of Adviser
7th Apr 20227:00 amRNSResults for the year ended 31 December 2021
2nd Mar 20224:30 pmRNSHolding(s) in Company
17th Feb 20224:02 pmRNSGrant of options
8th Feb 20227:00 amRNSSubscription and extension of Debt Facility
26th Jan 20227:00 amRNSContract win in the Americas
12th Jan 20227:00 amRNSIssue of Equity
11th Jan 20227:00 amRNSPre-close statement
20th Dec 20217:00 amRNSSuccessful Innovate UK Smart Award
20th Sep 20217:00 amRNSInterim results to 30 June 2021
22nd Jul 20213:48 pmRNSIssue of Equity
16th Jul 20217:00 amRNSIssue of Equity
8th Jul 20217:00 amRNSPre-close trading update
30th Jun 20212:06 pmRNSPosting of Accounts
28th May 20217:00 amRNSResult of AGM
27th May 20217:00 amRNSAGM Statement
28th Apr 20217:00 amRNSGrant of options
22nd Apr 20217:00 amRNSResults for the year ended 31 December 2020
13th Apr 202112:30 pmRNSNotice of results, AGM and investor presentation
30th Mar 202112:38 pmBUSEarly Repurchase - Replacement
29th Mar 202110:06 amBUSEarly Repurchase
9th Feb 202110:31 amRNSDirector Dealing
20th Jan 20217:00 amRNSPre-Close Statement and Director Appointment
5th Jan 20211:21 pmRNSHolding(s) in Company
24th Dec 20209:30 amRNSHolding(s) in Company
21st Dec 20207:00 amRNSUpdate on commercial activity and issue of equity
22nd Sep 20204:03 pmRNSDirector Dealing
21st Sep 20207:00 amRNSInterim results to 30 June 2020
3rd Aug 20209:38 amRNSHolding(s) in Company
22nd Jul 20207:00 amRNSGrant of Options
14th Jul 20209:17 amRNSHolding(s) in Company
9th Jul 20207:00 amRNSPre-close Trading Update
17th Jun 20205:00 pmRNSPosting of Accounts
3rd Jun 20203:43 pmRNSResult of AGM
3rd Jun 20207:00 amRNSAGM Statement
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSResults for the year ended 31 December 2019
24th Apr 20203:39 pmRNSNotice of Results
6th Apr 20202:06 pmRNSSecond Price Monitoring Extn
6th Apr 20202:00 pmRNSPrice Monitoring Extension
12th Mar 202012:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.